Literature DB >> 10355666

Surgical outcome in patients with epilepsy and dual pathology.

L M Li1, F Cendes, F Andermann, C Watson, D R Fish, M J Cook, F Dubeau, J S Duncan, S D Shorvon, S F Berkovic, S Free, A Olivier, W Harkness, D L Arnold.   

Abstract

High-resolution MRI can detect dual pathology (an extrahippocampal lesion plus hippocampal atrophy) in about 5-20% of patients with refractory partial epilepsy referred for surgical evaluation. We report the results of 41 surgical interventions in 38 adults (mean age 31 years, range 14-63 years) with dual pathology. Three patients had two operations. The mean postoperative follow-up was 37 months (range 12-180 months). The extrahippocampal lesions were cortical dysgenesis in 15, tumour in 10, contusion/infarct in eight and vascular malformation in five patients. The surgical approach aimed to remove what was considered to be the most epileptogenic lesion, and the 41 operations were classified into lesionectomy (removal of an extrahippocampal lesion); mesial temporal resection (removal of an atrophic hippocampus); and lesionectomy plus mesial temporal resection (removal of both the lesion and the atrophic hippocampus). Lesionectomy plus mesial temporal resection resulted in complete freedom from seizures in 11/15 (73%) patients, while only 2/10 (20%) patients who had mesial temporal resection alone and 2/16 (12.5%) who had a lesionectomy alone were seizure-free (P < 0.001). When classes I and II were considered together results improved to 86, 30 and 31%, respectively. Our findings indicate that in patients with dual pathology removal of both the lesion and the atrophic hippocampus is the best surgical approach and should be considered whenever possible.

Entities:  

Mesh:

Year:  1999        PMID: 10355666     DOI: 10.1093/brain/122.5.799

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  29 in total

1.  Does Dual Pathology Always Require Dual Resection?

Authors:  Ronald P. Lesser
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

2.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

3.  Presurgical evaluations of patients with intractable epilepsy.

Authors:  R P Lesser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

4.  Seizures in patients undergoing resection of low-grade gliomas.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

5.  Occult dual pathology in mesial temporal lobe epilepsy.

Authors:  Shin-Ichiro Osawa; Masaki Iwasaki; Hiroyoshi Suzuki; Nobukazu Nakasato; Teiji Tominaga
Journal:  Neurol Sci       Date:  2015-05-30       Impact factor: 3.307

6.  Surgical strategy for temporal lobe epilepsy with dual pathology and incomplete evidence from EEG and neuroimaging.

Authors:  Lan Luan; Yuqiang Sun; Kang Yang
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

Review 7.  Role of conventional magnetic resonance imaging in the screening of epilepsy with structural abnormalities: a pictorial essay.

Authors:  Xu Zhao; Zhiqiang Zhou; Wenzhen Zhu; Hongbing Xiang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

8.  Identification of the epileptogenic lobe in neocortical epilepsy with proton MR spectroscopic imaging.

Authors:  Susanne G Mueller; Kenneth D Laxer; Jerome A Barakos; Nathan Cashdollar; Derek L Flenniken; Peter Vermathen; Gerald B Matson; Michael W Weiner
Journal:  Epilepsia       Date:  2004-12       Impact factor: 5.864

Review 9.  Surgical strategies for pediatric epilepsy.

Authors:  Jian Guan; Michael Karsy; Katrina Ducis; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-04

10.  Patterns of hippocampal abnormalities in malformations of cortical development.

Authors:  M A Montenegro; D Kinay; F Cendes; A Bernasconi; N Bernasconi; A C Coan; L M Li; M M Guerreiro; C A M Guerreiro; I Lopes-Cendes; E Andermann; F Dubeau; F Andermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.